Fabrice Stock

Title: Fabrice Stock - Innovator in Nucleic Acid Transfection

Introduction: Fabrice Stock is an inventor based in Benfeld, France, known for his contributions to the field of nucleic acid transfection. He currently works at Polyplus Transfection, a company specializing in innovative solutions for gene delivery. Despite having no granted patents, his work is significant in advancing the methodologies used in genetic research and therapy.

Latest Patent Applications: Fabrice Stock has filed several notable patent applications, including:

1. **Compositions for Transfecting a Nucleic Acid Molecule into a Cell Comprising Benzo-Fused Heterocyclic Compounds Grafted to a Cationic Polymer, and Their Applications** - This application discloses compositions for transfecting nucleic acid molecules into cells, particularly eukaryotic cells. It includes specific compounds and their acceptable salts, along with excipients and transfection media.

2. **Compositions for Transfecting a Nucleic Acid Molecule into a Cell Comprising Triazole Compounds Grafted to a Cationic Polymer, and Their Applications** - This application also focuses on compositions for transfecting nucleic acid molecules into cells, detailing the use of triazole compounds and their formulations for effective transfection.

Conclusion: Fabrice Stock's innovative work at Polyplus Transfection highlights his commitment to advancing genetic research through effective nucleic acid delivery systems. His latest patent applications reflect his ongoing contributions to the field, showcasing the potential for future developments in gene therapy.